| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2400483 | Medical Mycology Case Reports | 2016 | 4 Pages |
Abstract
Echinocandin antifungal agents are not routinely recommended for the treatment of candiduria due to low urine concentrations and a paucity of clinical data supporting this indication. This report presents five cases describing the use of micafungin for the treatment of candiduria. Each patient received parenteral micafungin for a minimum of 6 days and had resolution of baseline fungal within 30 days of treatment completion.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Lauren E. Kane, Katie M. Muzevich,